West Paces Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $238K | Sell |
475
-27
| -5% | -$13K | 0.04% | 148 |
|
|
2026
Q1 | $247K | Sell |
502
-10
| -2% | -$5.43K | 0.05% | 140 |
|
|
2025
Q4 | $297K | Buy |
512
+40
| +8% | +$22.6K | 0.06% | 125 |
|
|
2025
Q3 | $229K | Buy |
+472
| New | +$220K | 0.05% | 139 |
|
|
2025
Q2 | – | Sell |
-490
| Closed | -$244K | – | 522 |
|
|
2025
Q1 | $244K | Hold |
490
| – | – | 0.06% | 122 |
|
|
2024
Q4 | $255K | Sell |
490
-11
| -2% | -$6.05K | 0.06% | 117 |
|
|
2024
Q3 | $310K | Hold |
501
| – | – | 0.08% | 110 |
|
|
2024
Q2 | $277K | Hold |
501
| – | – | 0.07% | 108 |
|
|
2024
Q1 | $291K | Sell |
501
-59
| -11% | -$33.1K | 0.08% | 107 |
|
|
2023
Q4 | $297K | Buy |
560
+14
| +3% | +$6.78K | 0.08% | 102 |
|
|
2023
Q3 | $276K | Sell |
546
-74
| -12% | -$39.4K | 0.09% | 103 |
|
|
2023
Q2 | $323K | Sell |
620
-50
| -7% | -$27K | 0.1% | 104 |
|
|
2023
Q1 | $386K | Buy |
670
+5
| +0.8% | +$2.82K | 0.12% | 93 |
|
|
2022
Q4 | $366K | Buy |
665
+40
| +6% | +$21.2K | 0.12% | 96 |
|
|
2022
Q3 | $317K | Sell |
625
-7
| -1% | -$3.92K | 0.11% | 99 |
|
|
2022
Q2 | $343K | Buy |
632
+30
| +5% | +$16.5K | 0.12% | 95 |
|
|
2022
Q1 | $356K | Buy |
602
+253
| +72% | +$145K | 0.11% | 97 |
|
|
2021
Q4 | $233K | Buy |
349
+7
| +2% | +$4.37K | 0.07% | 112 |
|
|
2021
Q3 | $195K | Buy |
342
+169
| +98% | +$92.8K | 0.07% | 116 |
|
|
2021
Q2 | $87.3K | Sell |
173
-41
| -19% | -$19.3K | 0.03% | 160 |
|
|
2021
Q1 | $97.7K | Sell |
214
-30
| -12% | -$14.3K | 0.04% | 141 |
|
|
2020
Q4 | $114K | Hold |
244
| – | – | 0.05% | 131 |
|
|
2020
Q3 | $108K | Sell |
244
-22
| -8% | -$9.09K | 0.06% | 130 |
|
|
2020
Q2 | $96.4K | Hold |
266
| – | – | 0.05% | 135 |
|
|
2020
Q1 | $75.4K | Buy |
266
+15
| +6% | +$4.73K | 0.05% | 143 |
|
|
2019
Q4 | $81.5K | Hold |
251
| – | – | 0.04% | 154 |
|
|
2019
Q3 | $73.1K | Hold |
251
| – | – | 0.04% | 154 |
|
|
2019
Q2 | $73.7K | Hold |
251
| – | – | 0.05% | 151 |
|
|
2019
Q1 | $68.7K | Hold |
251
| – | – | 0.05% | 154 |
|
|
2018
Q4 | $56.2K | Hold |
251
| – | – | 0.04% | 163 |
|
|
2018
Q3 | $61.3K | Hold |
251
| – | – | 0.04% | 162 |
|
|
2018
Q2 | $52K | Hold |
251
| – | – | 0.04% | 170 |
|
|
2018
Q1 | $51.8K | Hold |
251
| – | – | 0.04% | 165 |
|
|
2017
Q4 | $47.7K | Hold |
251
| – | – | 0.04% | 181 |
|
|
2017
Q3 | $47.5K | Hold |
251
| – | – | 0.04% | 178 |
|
|
2017
Q2 | $43.8K | Hold |
251
| – | – | 0.03% | 179 |
|
|
2017
Q1 | $38.6K | Hold |
251
| – | – | 0.03% | 185 |
|
|
2016
Q4 | $35.4K | Buy |
+251
| New | +$37K | 0.03% | 206 |
|
Other funds holding TMO
West Paces Advisors's TMO Position: Q2 2026 in Review
West Paces Advisors reduced its Thermo Fisher Scientific (TMO) stake by 5.4% in Q2 2026, selling an estimated $13K and leaving 475 shares worth $238K. The position accounts for 0.04% of the portfolio, ranked #148.
West Paces Advisors first reported a position in TMO in Q4 2016 and has held it in 38 quarters since. The position peaked at $386K in Q1 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- West Paces Advisors held 475 shares of Thermo Fisher Scientific worth $238K as of Q2 2026.
- West Paces Advisors sold 27 Thermo Fisher Scientific shares in Q2 2026, an estimated $13K.
- Thermo Fisher Scientific made up 0.04% of West Paces Advisors's portfolio in Q2 2026, its #148 holding.
- West Paces Advisors first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 38 quarters since.
- West Paces Advisors's Thermo Fisher Scientific position peaked at $386K in Q1 2023.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.